mRNA technology

Statistics report on the mRNA technology

mRNA technology

This report presents a range of statistics and facts about the mRNA (messenger ribonucleic acid) technology. It is well-known to the broader public due to the COVID-19 vaccines from Moderna and BioNTech/Pfizer, which are mostly used in the Western world. The report provides a good starting point to get to know the mRNA landscape, including its position within biotech, top companies, short-term and long-term outlooks, etc.

Table of contents

Overview

5
  • Basic Statistic Global pharmaceutical revenue by technology 2012-2026
  • Basic Statistic Percentage of global pharmaceutical sales by technology 2016-2030
  • Basic Statistic Top pharma and biotech companies by net sales growth in 2023
  • Basic Statistic Top 50 global pharmaceutical and biotech companies by R&D intensity in 2023
  • Premium Statistic Forecasted revenue of mRNA market revenue worldwide 2021-2035

Research and development

5
  • Premium Statistic Global funding in mRNA therapeutics and vaccines 2015-2020
  • Premium Statistic Clinical pipeline of mRNA therapeutics worldwide by therapy area 2021
  • Basic Statistic Clinical pipeline of mRNA prophylactic vaccines worldwide by therapy area 2021
  • Basic Statistic Clinical pipeline of mRNA therapeutic vaccines worldwide by therapy area 2021
  • Premium Statistic mRNA technology clinical pipelines worldwide by therapy area and stage 2021

COVID-19

6
  • Basic Statistic Forecasted COVID-19 vaccine share of total mRNA revenues globally 2021-2035
  • Premium Statistic Forecasted COVID-19 vaccine revenue share globally by technology 2026
  • Basic Statistic Bestselling COVID-19 vaccines and drugs worldwide in 1st HY 2021
  • Basic Statistic Drugs generating 10 billion U.S. dollars or more in annual sales worldwide 2021
  • Basic Statistic Forecasted sales of select COVID-19 vaccines worldwide 2021-2022
  • Premium Statistic COVID-19 vaccine development, enrollment and funding status July 28, 2020, by company

Leading companies

4
  • Premium Statistic Leading mRNA biotech companies' revenues 2022
  • Basic Statistic Leading mRNA biotech companies' net income 2022
  • Basic Statistic Leading mRNA biotech companies' R&D spending 2022
  • Basic Statistic Leading mRNA biotech companies' market cap 2025

Focus: Moderna

5
  • Basic Statistic Moderna's revenue 2016-2024
  • Basic Statistic Moderna net income 2016-2023
  • Basic Statistic R&D expenses of Moderna 2016-2024
  • Basic Statistic Moderna total assets 2016-2023
  • Basic Statistic Net Present Value of Moderna products worldwide 2021

Focus: BioNTech

4
  • Basic Statistic Revenue of BioNTech 2017-2024
  • Basic Statistic Operating income of BioNTech 2017-2024
  • Basic Statistic BioNTech earnings per share 2017-2024
  • Basic Statistic BioNTech total assets 2017-2024
Report this content

Statista report shop

Explore all Statista reports

We provide information on industries, companies, consumers, trends, countries, and politics, covering the latest and most important issues in a condensed format.

Statista report shop Go to reports
Contact

Get in touch with us. We are happy to help.

Meredith Alda
Sales Manager– Contact (United States)
Email
support@statista.com
Tel
+1 914 619-5895

Mon - Fri, 9am - 6pm (EST)

Yolanda Mega
Operations Manager– Contact (Asia)
Email
Tel
+65 6995 6959

Mon - Fri, 9am - 5pm (SGT)

Ayana Mizuno
Business Development Manager– Contact (Asia)
Email

Mon - Fri, 10:00am - 6:00pm (JST)

Lodovica Biagi
Director of Operations– Contact (Europe)
Email
Tel
+44 (0)20 8189 7000

Mon - Fri, 9:30am - 5pm (GMT)

Carolina Dulin
Group Director - LATAM– Contact (Latin America)
Email
Tel
+1 212 419-5774

Mon - Fri, 9am - 6pm (EST)